Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era is a research paper published in British Journal of Haematology (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30 CA008748
NCI NIH HHS
Grant: P50 CA192937
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5P50CA192937-02
MSK SPORE in Lymphoma
FWCI
0.23
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords